Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukikazu Hayashi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of General and Family Medicine|December 22, 2017
Cluster analysis of pharmacists' work attitudesKeiichi Nakagomi, Yukikazu Hayashi, Takako Komiyama
Therapeutic Innovation & Regulatory Science|October 28, 2024
Abstract Versus Concrete Risk Identification in Clinical Research in Japan: Randomized and Prospective Pilot Research on the Effect of Risk Reduction Activities in a Risk-Based ApproachHidenobu Kondo, Shih-Wei Chiu, Yukikazu Hayashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2024
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional declineTatsuto Hamatani, Naoki Atsuta, Fumiya Sano, et al.
Therapeutic Innovation & Regulatory Science|April 20, 2021
Evaluation of Data Errors and Monitoring Activities in a Trial in Japan Using a Risk-Based Approach Including Central Monitoring and Site Risk AssessmentHidenobu Kondo, Tomoaki Kamiyoshihara, Kenji Fujisawa, et al.
The Journal of Antibiotics|April 3, 2014
Streptomyces hokutonensis sp. nov., a novel actinomycete isolated from the strawberry root rhizosphereHideki Yamamura, Haruna Ashizawa, Moriyuki Hamada, et al.
Therapeutic Innovation & Regulatory Science|July 2, 2024
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in OncologyHiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of General and Family Medicine|December 22, 2017
Cluster analysis of pharmacists' work attitudesKeiichi Nakagomi, Yukikazu Hayashi, Takako Komiyama
Therapeutic Innovation & Regulatory Science|October 28, 2024
Abstract Versus Concrete Risk Identification in Clinical Research in Japan: Randomized and Prospective Pilot Research on the Effect of Risk Reduction Activities in a Risk-Based ApproachHidenobu Kondo, Shih-Wei Chiu, Yukikazu Hayashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2024
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional declineTatsuto Hamatani, Naoki Atsuta, Fumiya Sano, et al.
Therapeutic Innovation & Regulatory Science|April 20, 2021
Evaluation of Data Errors and Monitoring Activities in a Trial in Japan Using a Risk-Based Approach Including Central Monitoring and Site Risk AssessmentHidenobu Kondo, Tomoaki Kamiyoshihara, Kenji Fujisawa, et al.
The Journal of Antibiotics|April 3, 2014
Streptomyces hokutonensis sp. nov., a novel actinomycete isolated from the strawberry root rhizosphereHideki Yamamura, Haruna Ashizawa, Moriyuki Hamada, et al.
Therapeutic Innovation & Regulatory Science|July 2, 2024
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in OncologyHiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, et al.
Pageof 1